OncoDB 2.0: a comprehensive platform for integrated pan-cancer omics analysis
Nucleic Acids Research · 06.01.2026 · 54 (D1) · D1537-D1544
DOI: 10.1093/nar/gkaf952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 23.09.2025. Verfasst von Minsu Cho und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Regenerative Medicine, University of Illinois at Chicago, Chicago, IL 60612, United States. Hauptthemen laut MEDLINE: Neoplasms, Software, Genomics. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NIDCR NIH HHS, NIH HHS.
Abstract (Originalsprache)
OncoDB was initially developed to advance cancer research by integrating RNA expression profiles, DNA methylation patterns, clinical annotations, and oncoviral signatures derived from the Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression datasets. We now present OncoDB 2.0, an extensively expanded platform that offers a more comprehensive and integrated view of cancer omics. The updated version includes an atlas of somatic mutations discovered from combined DNA and RNA sequencing, enabling in-depth investigation of mutation patterns across tumor types and their association with clinical features. Furthermore, we have integrated proteomic data from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and chromatin accessibility data from TCGA, offering new dimensions for oncogene regulation studies. OncoDB 2.0 also introduces advanced multi-omics analysis modules that facilitate the combined exploration of RNA expression, DNA methylation, and somatic mutations, allowing researchers to examine complex cross-omic relationships with greater depth and flexibility. Together, these enhancements make OncoDB 2.0 a robust and invaluable tool for the cancer research community. OncoDB 2.0 is freely available at https://oncodb.org.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pharmacology and Regenerative Medicine, University of Illinois at Chicago, Chicago, IL 60612, United States.
- Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL 60612, United States.
- University of Illinois Cancer Center, Chicago, IL 60612, United States.
ORCID-Profile: Xiaowei Wang
Förderung
- NIGMS NIH HHS
- NIDCR NIH HHS
- NIH HHS
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Cho, M., Tang, G., Rogers, C. S., Dove, M., Liu, X., Li, Y., & Wang, X. (2026). OncoDB 2.0: a comprehensive platform for integrated pan-cancer omics analysis. Nucleic Acids Research, 54(D1), D1537-D1544. https://doi.org/10.1093/nar/gkaf952
Vancouver
Cho M, Tang G, Rogers CS, Dove M, Liu X, Li Y, et al. OncoDB 2.0: a comprehensive platform for integrated pan-cancer omics analysis. Nucleic Acids Research. 2026;54(D1):D1537-D1544. doi:10.1093/nar/gkaf952
BibTeX
@article{Cho2026,
author = {Cho, Minsu and Tang, Gongyu and Rogers, Charles S and Dove, Makayla and Liu, Xinyi and Li, Yuanxiang and Wang, Xiaowei},
title = {OncoDB 2.0: a comprehensive platform for integrated pan-cancer omics analysis},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {D1},
pages = {D1537--D1544},
doi = {10.1093/nar/gkaf952}
}
EUVIMED